Baird Melissa's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed Mar 27, 2025
- Accession no.
- 0001773751-25-000106
- Filed
- Mar 27, 2025, 5:04 PM ET
- Trade date
- Mar 26, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.36M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Baird MelissaCIK 0001837815 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 26, 2025 | Class A Common Stock | MOption exerciseAcquired | +67,687 | $0.40 | +$27,074.8 | 818,930 | Direct | |
| Mar 26, 2025 | Class A Common Stock | SSaleDisposed | −18,262 | $33.57F2 | −$613,071.78 | 800,668 | Direct | |
| Mar 26, 2025 | Class A Common Stock | SSaleDisposed | −18,941 | $34.50F3 | −$653,489.12 | 781,727 | Direct | |
| Mar 26, 2025 | Class A Common Stock | SSaleDisposed | −22,558 | $35.37F4 | −$797,962.18 | 759,169 | Direct | |
| Mar 26, 2025 | Class A Common Stock | SSaleDisposed | −3,241 | $36.60F5 | −$118,617.36 | 755,928 | Direct | |
| Mar 26, 2025 | Class A Common Stock | SSaleDisposed | −4,685 | $37.35F6 | −$175,004.43 | 751,243 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 26, 2025 | Class A Common Stock | MOption exerciseDisposed | −67,687 | $0.00 | $0 | 54,556 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $33.295 - $33.97. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $34.065 - $34.98. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $35.02 - $35.915. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $36.045 - $36.93. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $37.175 - $37.59. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.